Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen

BACKGROUND: Honokiol (HON) inhibits epidermal growth factor receptor (EGFR) signaling and increases the activity of erlotinib, an EGFR inhibitor, in human head and neck cancers. In this study, using a bioinformatics approach and in vitro experiments, we assessed the target genes of HON against breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermawan, Adam, Putri, Herwandhani, Hanif, Naufa, Fatimah, Nurul, Prasetio, Heri Himawan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806337/
https://www.ncbi.nlm.nih.gov/pubmed/36601474
http://dx.doi.org/10.3389/fonc.2022.1019025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806337/
https://www.ncbi.nlm.nih.gov/pubmed/36601474
http://dx.doi.org/10.3389/fonc.2022.1019025

Ejemplares similares